BNP Paribas Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.4K Sell
1,172
-106
-8% -$2.31K ﹤0.01% 1911
2026
Q1
$22.2K Buy
1,278
+360
+39% +$6.81K ﹤0.01% 2006
2025
Q4
$17K Buy
918
+206
+29% +$3.45K ﹤0.01% 1999
2025
Q3
$10K Buy
712
+114
+19% +$1.63K ﹤0.01% 1623
2025
Q2
$12K Buy
+598
New +$10.6K ﹤0.01% 1704

Other funds holding CDNA

BNP Paribas Asset Management's CDNA Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its CareDx (CDNA) stake by 8.3% in Q2 2026, selling an estimated $2.31K and leaving 1,172 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1911.

BNP Paribas Asset Management first reported a position in CDNA in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • BNP Paribas Asset Management held 1,172 shares of CareDx worth $33.4K as of Q2 2026.
  • BNP Paribas Asset Management sold 106 CareDx shares in Q2 2026, an estimated $2.31K.
  • CareDx made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1911 holding.
  • BNP Paribas Asset Management first reported a position in CareDx in Q2 2025 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.